Quick Answer
CONOCOPHILLIPS reported Cash and Equivalents of $6.50 billion for fiscal year 2025.
CONOCOPHILLIPS Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $6.50B | +15.9% |
| 2024 | $5.61B | -0.5% |
| 2023 | $5.63B | -12.7% |
| 2022 | $6.46B | +28.4% |
| 2021 | $5.03B | +68.1% |
| 2020 | $2.99B | -41.2% |
| 2019 | $5.09B | -14.0% |
| 2018 | $5.92B | -6.5% |
| 2017 | $6.33B | +75.2% |
| 2016 | $3.61B | +52.4% |
| 2015 | $2.37B | -53.2% |
| 2014 | $5.06B | -19.0% |
| 2013 | $6.25B | +72.6% |
| 2012 | $3.62B | -37.4% |
| 2011 | $5.78B | -38.9% |
| 2010 | $9.45B | +1644.3% |
| 2009 | $542.00M | -28.2% |
| 2008 | $755.00M | -48.1% |
| 2007 | $1.46B | +78.2% |
| 2006 | $817.00M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $5.26B | +0.7% | +7.3% |
| June 30, 2025 | $4.90B | +14.1% | -22.3% |
| March 31, 2025 | $6.31B | +13.2% | +12.5% |
| December 31, 2024 | $5.61B | -0.5% | +7.4% |
| September 30, 2024 | $5.22B | -40.9% | +21.6% |
| June 30, 2024 | $4.29B | -25.1% | -23.0% |
| March 31, 2024 | $5.57B | -20.1% | -1.1% |
| December 31, 2023 | $5.63B | -12.7% | -36.2% |
- CONOCOPHILLIPS showed an increase of +15.9% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2006–2025 period, CONOCOPHILLIPS’s cash and equivalents has grown by 695.2% (from $817.00 million to $6.50 billion).
- The most recent figure is from CONOCOPHILLIPS’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: